Caricamento...
COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development
Novel 2019 coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) and coronavirus disease 2019 (COVID-19), the respiratory syndrome it causes, have shaken the world to its core by infecting and claiming the lives of many people since originating in December 2019 in Wuhan, China....
Salvato in:
| Pubblicato in: | Exp Biol Med (Maywood) |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8283249/ https://ncbi.nlm.nih.gov/pubmed/33757336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370221999989 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|